Jump to content

PubMed RSS Feed - - Brimonidine tartrate for the treatment of facial flushing and erythema in rosacea.


rss

Recommended Posts

Brimonidine tartrate for the treatment of facial flushing and erythema in rosacea.

Expert Rev Clin Pharmacol. 2014 Aug 4;:1-11

Authors: Tong LX, Moore AY

Abstract
Rosacea is a chronic inflammatory dermatologic condition that can often be disfiguring with significant negative impact on patients' quality of life. Sanrosa (brimonidine tartate) is a novel therapeutic agent targeting the facial flushing and erythema of rosacea through its α2 adrenergic receptor agonist activity. The goal of this article is to discuss current treatment options for rosacea and the properties of brimonidine tartate as well as the evidence surrounding its efficacy and safety profile.

PMID: 25091290 [PubMed - as supplied by publisher]

http://www.ncbi.nlm.nih.gov/pubmed/25091290?dopt=Abstract = URL to article

Link to comment
Share on other sites

Join the conversation

You can post now and register later. If you have an account, sign in now to post with your account.
Note: Your post will require moderator approval before it will be visible.

Guest
Reply to this topic...

×   Pasted as rich text.   Paste as plain text instead

  Only 75 emoji are allowed.

×   Your link has been automatically embedded.   Display as a link instead

×   Your previous content has been restored.   Clear editor

×   You cannot paste images directly. Upload or insert images from URL.

×
×
  • Create New...